Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|February 19, 2026
Regulating the regulators via targeting CD38 in the tumor microenvironmentNavnita Dutta, Nabanita Halder, Eduardo Nunes Chini, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 24, 2021
Trends in Early Mortality From Multiple Myeloma: A Population-Based AnalysisVivek Kumar, Meghna Ailawadhi, Navnita Dutta, et al.
Blood Advances|May 19, 2020
Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responsesAlak Manna, Timothy Kellett, Sonikpreet Aulakh, et al.
British Journal of Haematology|January 29, 2024
A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemiaRicardo D Parrondo, Navnita Dutta, Betsy R LaPlant, et al.
Cancers|January 21, 2023
AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple MyelomaSikander Ailawadhi, Ricardo D Parrondo, Navnita Dutta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2022
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic MalignancyJing Deng, Aneel Paulus, Douglas D Fang, et al.
Pageof 1